Hans Hammers, MD, PhD

Articles by Hans Hammers, MD, PhD

Dr. Hammers on Challenges With CAR T-Cell Therapy in RCC

September 16th 2019

Hans Hammers, MD, PhD, associate professor of internal medicine, Division of Hematology-Oncology, UT Southwestern Medical Center, discusses the challenges with using CAR T-cell therapy in renal cell carcinoma.

Latest Updated Articles

Dr. Hammers on Challenges With CAR T-Cell Therapy in RCC
Published: September 16th 2019 | Updated:

Hans Hammers, MD, PhD

Articles by Hans Hammers, MD, PhD

Dr. Hammers on Challenges With CAR T-Cell Therapy in RCC

Latest Updated Articles

Trending on CGTlive®

Patients Treated With AskBio’s Limb-Girdle Muscular Dystrophy Gene Therapy AB-1003 Free of Serious Adverse Events at Up to 52 Weeks

CGTLive®’s Weekly Rewind – October 17, 2025